Tjang Yanto Sandy, Stenlund Hans, Tenderich Gero, Hornik Lech, Körfer Reiner
Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center, NRW/University Hospital of Bochum, Bad Oeynhausen, Germany.
J Card Surg. 2008 Jan-Feb;23(1):87-91. doi: 10.1111/j.1540-8191.2007.00494.x.
Heart failure has been recognized as a major public health problem. Its incidence and prevalence is increasing and imposes substantial burden on the health care system. Despite much progress in development of many new drugs and innovations in palliative surgical strategy, nontransplant cardiac surgical procedures and the use of mechanical assist devices, pediatric heart transplantation remains the best treatment option for patients with end-stage heart failure. So far, more than 6000 pediatric heart transplantations have been performed worldwide. This article reviews some clinical aspects of pediatric heart transplantation, including the history, indications and contraindications, donor evaluation and recipient management, surgical techniques, risk factors of mortality, and survival of pediatric heart transplantation. The short- and long-term outcomes of pediatric heart transplantation are encouraging. However, the lack of donor hearts still hampers its clinical application.
心力衰竭已被公认为一个主要的公共卫生问题。其发病率和患病率不断上升,给医疗保健系统带来了沉重负担。尽管在许多新药研发以及姑息性手术策略、非移植心脏外科手术和机械辅助装置的使用方面取得了很大进展,但小儿心脏移植仍然是终末期心力衰竭患者的最佳治疗选择。到目前为止,全球已进行了6000多例小儿心脏移植手术。本文综述了小儿心脏移植的一些临床方面,包括历史、适应证和禁忌证、供体评估和受体管理、手术技术、死亡风险因素以及小儿心脏移植的生存率。小儿心脏移植的短期和长期结果令人鼓舞。然而,供体心脏的短缺仍然阻碍了其临床应用。